Olga Berson of Thompson Coburn LLP discusses opportunities as well as intellectual property pitfalls for sovereign wealth ...

The global prostate cancer diagnostics market is expected to grow at a CAGR of ~12% during the forecast period. Rising ...

The custom antibody market is set to witness a CAGR of ~10% during the forecast period. The market growth is primarily driven ...

Newly launched ophthalmology company Ollin Biosciences has emerged onto the scene with $100 million in backing and a mission to bring a rival drug for wet age-related macular degeneration (AMD) that ...

Vietnam’s cold-chain and agritech upgrades cut losses and raise export margins, creating strong opportunities for foreign ...

Madison Investments, an investment advisor, released its “Madison Mid Cap Fund” second-quarter 2025 investor letter. A copy ...

Bolstered by world-class centers of learning such as Harvard University and the Massachusetts Institute of Technology, Boston ...

Inmazeb®(atoltivimab, maftivimab, and odesivimab-ebgn) was the first treatment approved by the U.S. Food and Drug Administration (FDA) for Orthoebolavirus zairense, also known as Zaire ebolavirus ...

That's a challenge for her own Ph.D. students, some of whom study Antarctic mammals and seabirds. Prof. Rogers advises them ...

New research reveals American adults face a devastating hidden health collapse. Cardiovascular aging accelerates dramatically ...

Austria has launched a major initiative to attract Indian students to its leading technical universities, aiming to address its "great demand" for skilled labour. Speaking to ANI, Austrian Ambassador ...

The prospect of further interest-rate cuts from the Federal Reserve is finally giving diehard believers in the biotechnology ...